home / stock / avtr / avtr quote
Last: | $21.09 |
---|---|
Change Percent: | -1.01% |
Open: | $21.06 |
Close: | $21.09 |
High: | $21.215 |
Low: | $20.825 |
Volume: | 5,857,278 |
Last Trade Date Time: | 07/22/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$21.09 | $21.06 | $21.09 | $21.215 | $20.825 | 5,857,278 | 07-22-2024 |
$20.85 | $20.58 | $20.85 | $20.97 | $20.52 | 5,883,105 | 07-19-2024 |
$20.74 | $21.38 | $20.74 | $21.515 | $20.495 | 11,775,194 | 07-18-2024 |
$21.42 | $21.45 | $21.42 | $21.66 | $21.175 | 8,187,564 | 07-17-2024 |
$21.53 | $21.13 | $21.53 | $21.54 | $20.92 | 4,402,598 | 07-16-2024 |
$20.82 | $20.88 | $20.82 | $21.005 | $20.69 | 5,229,135 | 07-15-2024 |
$20.8 | $21.31 | $20.8 | $21.31 | $20.6 | 8,037,585 | 07-12-2024 |
$21.29 | $20.97 | $21.29 | $21.505 | $20.9 | 4,915,562 | 07-11-2024 |
$20.9 | $20.51 | $20.9 | $20.94 | $20.51 | 4,755,283 | 07-10-2024 |
$20.88 | $21.04 | $20.88 | $21.055 | $20.705 | 2,636,132 | 07-09-2024 |
$20.94 | $21.17 | $20.94 | $21.21 | $20.715 | 3,895,937 | 07-08-2024 |
$21.03 | $20.97 | $21.03 | $21.11 | $20.75 | 5,272,924 | 07-05-2024 |
$21.01 | $20.58 | $21.01 | $21.08 | $20.56 | 5,206,885 | 07-04-2024 |
$21.01 | $20.58 | $21.01 | $21.08 | $20.56 | 5,206,885 | 07-03-2024 |
$20.58 | $20.62 | $20.58 | $20.705 | $20.49 | 5,348,864 | 07-02-2024 |
$20.77 | $21.28 | $20.77 | $21.34 | $20.625 | 5,993,342 | 07-01-2024 |
$21.2 | $21.46 | $21.2 | $21.47 | $20.98 | 9,536,567 | 06-28-2024 |
$21.42 | $21.83 | $21.42 | $21.905 | $21.3 | 7,087,012 | 06-27-2024 |
$21.95 | $22.03 | $21.95 | $22.08 | $21.78 | 6,341,574 | 06-26-2024 |
$22.07 | $22.41 | $22.07 | $22.55 | $22.02 | 4,991,320 | 06-25-2024 |
News, Short Squeeze, Breakout and More Instantly...
2024-07-02 09:15:03 ET Evercore ISI analyst issues OUTPERFORM recommendation for AVTR on July 2, 2024 07:56AM ET. The previous analyst recommendation was Outperform. AVTR was trading at $20.77 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
Avantor® Announces New J.T.Baker® Cell Lysis Solution and J.T.Baker® Endonuclease PR Newswire Innovative Solutions Optimize the Harvest Process in Gene Therapy Manufacturing Sustainably and at Scale RADNOR, Pa. , July 1, 2024 /PRNewswire/ -- Av...
Avantor® to Host Second Quarter 2024 Earnings Call on Friday, July 26, 2024 PR Newswire RADNOR, Pa. , June 28, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life scien...